Podcasts about Melanoma

Send Zorba a message!Zorba's thoughts on the groundbreaking mRNA therapeutic vaccine to combat melanoma.Support the showProduction, edit, and music by Karl ChristensonSend your question to Dr. Zorba (he loves to help!):Phone: 608-492-9292 (call anytime)Email: askdoctorzorba@gmail.comWeb: www.doctorzorba.orgStay well!

This episode highlights three clinically relevant developments: positive phase 3 results for individualized mRNA neoantigen therapy plus pembrolizumab after melanoma surgery, emerging MRI and AI approaches that may identify Alzheimer's-related brain changes years earlier, and substantial LDL-C treatment gaps under the 2026 ACC/AHA dyslipidemia guideline. Together, the findings underscore advances in precision oncology, early neurodegenerative risk detection, and cardiovascular prevention.

P.M. Edition for Aug. 24. Treasury Secretary Scott Bessent says the U.S. will go after countries and companies that do business with Iran. White House economic policy reporter Brian Schwartz says it's unclear what will happen with Iran's top trading partner: China. Plus, President Trump escalates the trade conflict with Canada, threatening 50% tariffs on autos. And Heard on the Street columnist David Wainer discusses the challenges Moderna faces in fulfilling investor hopes for a sweeping new era for cancer treatment. Pierre Bienaimé hosts. The AI Therapist: A WSJ Podcast Series  Sign up for the WSJ's free What's News newsletter. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

On the heels of consequential primary race results, some of the big winners join the program. Plus, President Trump says that North Korea has 57 powerful nuclear weapons. Also, an experimental vaccine shows promising results for patients with melanoma.  Learn more about your ad choices. Visit podcastchoices.com/adchoices

The world's okayest morning radio show offers you the entire broadcast from today with none of the music and limited commercials. Try to enjoy!

Friday 21 August 2026 Unemployment rises as bond markets pare back the chance of a rate hike. The Aussie dollar pushes above 71 US cents Federal parliament passes legislation that will force big tech companies to pay hundreds of millions of dollars to local media organisations The football World Cup both helps, and hurts, ASX listed companies A promising new treatment for melanoma Hit follow on the podcast so you don’t miss the latest news, and join our free daily newsletter here. And don’t miss the latest episode of How Do They Afford That? - ten purchases that actually save you money. Get the episode from Apple, Spotify or anywhere you listen to podcasts.Find out more: https://fearandgreed.com.au/See omnystudio.com/listener for privacy information.

Plus: Target's second-quarter sales suggest the retailer's turnaround is working. And Cantor Fitzgerald plans to give its hedge-fund clients access to Kalshi's prediction markets. Alex Ossola hosts. Sign up for WSJ's free What's News newsletter. An artificial-intelligence tool assisted in the making of this episode by creating summaries that were based on Wall Street Journal reporting and reviewed and adapted by an editor. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

WS: prima seduta in rialzo dopo 3 in calo; Tbond comprati, il tesoro raddoppia il buyback; Moderna +177% con farmaco anti melanoma; Usa-Canada verso accordo commerciale; Nordcorea: Trump vuole rivedere Kim Jong Un Puntata a cura di Stefania Spatti - Class CNBC Learn more about your ad choices. Visit megaphone.fm/adchoices

Please visit answersincme.com/GFY860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Vishal A. Patel, MD; and Jonathan S. Zager, MD, FACS, FSSO. In this activity, experts in cutaneous oncology discuss the evolving role of gene expression profiling (GEP) tests in refining risk assessment and supporting individualized, multidisciplinary management strategies for patients with melanoma. Upon completion of this activity, participants should be better able to: Identify the clinical rationale for using GEP tests to stratify the risk of disease progression in patients with cutaneous melanoma; Review the clinical evidence, including guideline-supported data, for GEP tests to stratify disease progression risk in patients with cutaneous melanoma; Formulate multidisciplinary strategies for incorporating the results of GEP tests into risk-based management of patients with cutaneous melanoma; and Outline patient-centered approaches to integrating GEP tests into the management of patients with cutaneous melanoma at risk of metastasis.

Please visit answersincme.com/GFY860 to participate, download slides and supporting materials, complete the post test, and get a certificate. Presented by Vishal A. Patel, MD; and Jonathan S. Zager, MD, FACS, FSSO. In this activity, experts in cutaneous oncology discuss the evolving role of gene expression profiling (GEP) tests in refining risk assessment and supporting individualized, multidisciplinary management strategies for patients with melanoma. Upon completion of this activity, participants should be better able to: Identify the clinical rationale for using GEP tests to stratify the risk of disease progression in patients with cutaneous melanoma; Review the clinical evidence, including guideline-supported data, for GEP tests to stratify disease progression risk in patients with cutaneous melanoma; Formulate multidisciplinary strategies for incorporating the results of GEP tests into risk-based management of patients with cutaneous melanoma; and Outline patient-centered approaches to integrating GEP tests into the management of patients with cutaneous melanoma at risk of metastasis.

Entrevista a Olga Vera, investigadora principal del Hospital público La Paz, de un estudio en el que identifican una proteína que explica la elevada agresividad del melanoma

In today's episode, we spoke with Marlana M. Orloff, MD. Dr Orloff is the Alexander & Johnston Family Endowed Clinical Director in Uveal Melanoma, and associate professor at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. In our exclusive interview, Dr Orloff discussed the distinct biology of uveal melanoma and why it has historically resisted systemic treatment. Unlike cutaneous melanoma, which carries a high tumor mutational burden and responds robustly to immune checkpoint inhibitors, uveal melanoma sits at the opposite end of the spectrum with low mutational burden, a predominantly liver-metastatic pattern, and an immune-tolerant microenvironment that renders traditional immunotherapy largely ineffective.She provided context on the treatment landscape for patients with HLA-A*02:01–negative metastatic uveal melanoma prior to the phase 2/3 OptimUM-02 trial (NCT05987332), noting that this population had limited options: liver-directed therapies such as percutaneous hepatic perfusion, off-label immune checkpoint inhibitor combinations, or clinical trial enrollment.Dr Orloff then walked through the design and efficacy findings of the trial, which evaluated the combination of darovasertib, an oral PKC inhibitor, plus crizotinib (Xalkori), a MET inhibitor, vs investigator's choice in treatment-naive, HLA-A*02:01–negative patients. The combination demonstrated a median progression-free survival of 6.9 months vs 3.1 months with investigator's choice, with an objective response rate of 37.1% compared with under 5.8% in the control arm. She highlighted the clinical significance of the complete responses observed while noting that overall survival data from the phase 3 portion of the trial remain pending.The discussion also addressed the growing complexity of treatment sequencing as more options emerge, including tebentafusp-tebn (Kimmtrak) for HLA-A*02:01–positive patients, liver-directed and combination approaches, and the investigational TCR-engineered T-cell therapy anzutresgene autoleucel targeting PRAME. Dr Orloff emphasized that in the absence of head-to-head comparisons, sequencing decisions will increasingly be shaped by patient logistics, toxicity profiles, and access to specialized treatment centers.

Connect with us via text! In this episode, the DERMASCOPE in-house aesthetician team explores the growing culture of prevention, longevity, and beauty optimization, including a promising personalized mRNA vaccine for melanoma recurrence and what it could signal for the future of skin cancer prevention, the booming longevity movement, and the role aesthetics plays in proactive wellness. Plus, they unpack the rising cost of pre-wedding beauty prep, questioning why so many are willing to spend thousands – and sometimes go into debt – to look their best for one day. Be sure to follow us on social media and your favorite podcast listening platforms for the inside scoop on the current events affecting the aesthetics industry! Follow DERMASCOPE:Instagram: @dermascopeFacebook: facebook.com/dermascopePinterest: @dermascopeTikTok: @dermascope                                                                                                 YouTube: youtube.com/@dermascopeFollow Elizabeth & LoniceElizabeth Brasher Instagram: @theskingalLonice Stoker Instagram: @lacedbylonicespaAdditional Links:Visit our website.Learn more about this podcast.Subscribe to the magazine.Read the July 2026 issue.Read the 2026 P&E Guide.

In this episode of Onc Now, Vernon Sondak reflects on the remarkable evolution of melanoma care over the course of his career. He discusses how breakthroughs in surgery, immunotherapy, targeted therapies, and neoadjuvant treatment have transformed outcomes for patients with melanoma and influenced treatment strategies across oncology. The conversation also explores the challenges of paediatric melanoma, the importance of multidisciplinary collaboration, and the future priorities for melanoma research and patient care.  Timestamps:   00:00 – Introduction   01:30 - Melanoma Care Through the Years   06:52 - Sentinel Node Biopsy Impact Today   12:28 - Paediatric Melanoma Care Challenges   21:45 - Collaboration Driving Melanoma Progress   24:57 - Translating Research into Patient Care   31:30 - Exciting Advances in Systemic and Neoadjuvant Therapy   39:06 - Three Wishes for Melanoma Care 

This week, Bobbi Conner talks with MUSC's Dr. Russell Jenkins about new treatments for advanced melanoma.

Sunspots usually stay flat and stable over time, while skin cancer often changes shape, color, texture, or sensation as abnormal cells grow and spread Melanoma warning signs follow the ABCDE rule: asymmetry, irregular borders, uneven color, larger diameter, and evolution over time, giving you a simple way to check your own skin each month Many sunspots contain lipofuscin, a waste pigment that researchers believe may form when linoleic acid from seed oils oxidizes in the presence of excess iron and sunlight Elevated ferritin and GGT levels have been associated with higher oxidative stress, which some researchers suggest may be reflected in the skin Lowering seed oil intake, reducing excess iron, using sunlight strategically, and acting quickly when a spot changes may help reduce oxidative stress on the skin and support earlier detection of changes

Dr. Hensin Tsao on Mentorship, Writing, and Defining Success Beyond TitlesChristine welcomes Dr. Hensin Tsao, Harvard Dermatology Professor and Director of melanoma programs at Mass General, who shares a pivotal early-career moment: stepping in for a WHO Melanoma Congress talk on genetics that led to new opportunities and reinforced the value of serendipity and mentorship. He advises giving every talk full effort regardless of audience size, focusing on turning “light bulbs” on for learners, and building an academic career through continual writing and strong communication, which he argues AI cannot fully replace in crafting persuasive, poetic narrative. Tsao reflects that titles are responsibilities, not validation, and warns that career moves can carry disruptive family costs. He discusses leadership lessons about recognizing differing goals in trainees, and describes his identities as explorer, clinician-guide using evidence to reduce suffering, and youth soccer coach. He closes by urging listeners to choose their own “destination” in life and work.00:00 Welcome and Guest Intro01:44 Serendipity Breakthrough Story04:16 Give Every Talk Your Best06:18 Write to Thrive in Academia08:29 Titles Versus Responsibility13:31 Identity as Explorer Clinician Coach17:27 Final Advice Pick Your Destination

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/RNZ865. CME/MOC/AAPA/IPCE credit will be available until June 30, 2027.Moving Immunotherapy FORWARD in Melanoma: FOrum on Real-World Applications of Recent Data for Community Practice In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.SupportThis activity is supported through independent educational grants from Bristol Myers Squibb and Merck & Co., Inc., Rahway, NJ, USA.Disclosure information is available at the beginning of the video presentation.

In 2014 Katie was given 16 months to live following her diagnosis of stage 4 uveal melanoma. Preserving hope amidst daunting challenges, and embracing humor in the darkest of hours, Katie credits her survival to a blend of Western medicine and alternative healing factors like exercise, affirmations, and diet. Today, she lives in Denver, Colorado, with her husband, Nick. Katie has been NED since 2021. https://futurehappyself.com IG: @ceortman  LinkedIn: https://www.linkedin.com/in/katieortman/ Facebook: https://www.facebook.com/katie.ortman.9 Links to articles:  www.liinks.co/katiedoble Read Katie's article published in The Huffington Post  “My Doctor Said I Had 16 Months To Live. I'd Be Dead Right Now If I Had Listened.”  _______ To learn more about the 10 Radical Remission Healing Factors, connect with a certified RR coach or join a virtual or in-person workshop visit www.radicalremission.com.   To learn more about Radical Remission health coaching with Liz or Karla, Click Here   Join our mailing list and you'll receive our free eBook, Kickstart Your Healing: 20 Radical Remission Tips, as a special thank you for joining. Subscribe Here   To watch Episode 1 of the Radical Remission Docuseries for free, visit our YouTube channel here. To purchase the full 10-episode Radical Remission Docuseries visit Hay House Online Learning. Follow us on Social Media: Facebook  Instagram YouTube ______ Our Sponsors: When you hear the words, "You have cancer," everything changes. The fear. The uncertainty. The quiet hope that there has to be another way. At Hope4Cancer, there is. For more than 26 years, Dr. Tony Jimenez and his world-class medical team have welcomed more than 5,000 patients from more than 70 countries to their oceanfront treatment centers in Cancún and Playas de Tijuana, Mexico. Their integrative, personalized approach is built around a simple belief: cancer care should support the whole person — body, mind, and spirit. Every patient receives an individualized program guided by Dr. Tony Jimenez's 7 Key Principles of Cancer Therapy.  Whether you are newly diagnosed, exploring integrative options, or seeking support alongside conventional treatment, you don't have to walk this road alone. You deserve options. You deserve hope. Healing starts with hope. Learn more about Hope4Cancer: Visit hope4cancer.com today for your free consultation. _______________ Nestled in the pristine, natural beauty of British Columbia, The Healing Oasis stands as Canada's first-of-its-kind cancer wellness retreat, where hope reignites and the body is empowered to heal. Here, our renowned naturopathic cancer expert, Dr. Sean Ceaser, designs a fully personalized protocol of advanced, non-toxic therapies—including high-dose IVs like mistletoe and vitamin C, cutting-edge hyperthermia, PEMF, oxygen therapy, red light, and more. Savor daily organic, cancer-fighting meals, rest deeply in serene cabins, immerse in restorative activities like forest walks and yoga, drink mineral-rich living water, and receive emotional support in a peaceful sanctuary that combines world-class care with profound nature immersion to reduce side effects, boost vitality, and spark radical healing. Your journey to feeling alive again begins today at thehealingoasis.ca. Learn More about The Healing Oasis: Website   Testimonials Video Overview    

What does it mean to truly live well after a melanoma diagnosis?In this heartfelt episode of Beyond the Clinic: Living Well with Melanoma, Dr. Samantha Siegel sits down with melanoma advocate Mary Margaret Braddock to discuss her journey from a Stage IB melanoma diagnosis at age 40 through three recurrences—and ultimately to no evidence of disease.Mary Margaret shares the emotional realities of living with uncertainty, balancing hope and fear, navigating survivorship, and discovering purpose through advocacy. Together, she and Dr. Siegel explore the challenges that often continue long after treatment ends, including scan anxiety, post-traumatic growth, finding a "new normal," and the healing power of connecting with others who understand the experience.This inspiring conversation reminds us that survivorship isn't simply about reaching the end of treatment—it's about learning how to live fully while carrying both the challenges and the gifts that cancer can leave behind.In this episode, you'll learn about:Living through multiple melanoma recurrencesCoping with uncertainty and scan anxietyThe emotional journey of survivorshipFinding meaning through patient advocacyThe value of peer support and connecting with othersBuilding resilience while embracing life's new normalWhy community can be one of the most powerful forms of healingWhether you're newly diagnosed, living with melanoma, supporting a loved one, or navigating life after treatment, this conversation offers encouragement, practical wisdom, and hope for the road ahead.About our Guest: Mary Margaret Braddock was initially diagnosed in 2016 with stage 1B melanoma at just 40 years old. Over the next decade, she experienced three additional recurrences; as of December 2025, she has no evidence of disease. Her personal battle with melanoma has motivated her to raise awareness, fund research, and advocate for other patients. Her engaging personality makes her a natural public speaker, leading to invitations to school events and appearances in local media, where she encourages newly diagnosed patients and connects with fellow survivors. Since 2023, Mary Margaret has served as Chair of AIM at Melanoma's Steps Against Melanoma walk in Tampa, Florida. This role has been especially meaningful to her because it afforded her the opportunity to raise funds for melanoma research while promoting sun safety in her home state. Most recently, her advocacy work has included attending the Melanoma Research Foundation's Hill Day events and the Melanoma Research Alliance Research Retreat, where she contributed the patient perspective to their ongoing efforts. Mary Margaret's journey has been both physical and emotional. At every stage, she has navigated the coexistence of shock and survival, gratitude and grief, and setbacks and growth. She says that embracing this balance is the key to holding on to hope and adapting to a new normal. 

This week, Bobbi Conner talks with MUSC's Dr. Graciela De Jesus about reducing risk of melanoma and other skin cancers.

HEALTH NEWS   Melatonin may safely reduce chronic musculoskeletal pain, study finds Study: Nordic Walking Reduces Depression Symptoms Within Weeks Connection or compulsion: How smartphones can deepen depression in older adults This Popular Workout Supplement May Give Cancer Immunotherapy a Big Boost Probiotic metabolite found to suppress melanoma tumor growth in mice   Melatonin may safely reduce chronic musculoskeletal pain, study finds University of Sydney, June 30 2026 (News-Medical) A sleep supplement widely used to treat insomnia could help reduce reliance on some of the most common and potentially harmful pain medications, new research from the University of Sydney suggests.  Published in PAIN, the study found melatonin can reduce chronic musculoskeletal pain with effects in a similar range to medications such as opioids, non-steroidal anti-inflammatory drugs (NSAIDs) and paracetamol.  The study analyzed data from 2028 adults across 23 randomised controlled trials conducted in countries including the United States, Russia, Brazil, Egypt and China. Participants included people with conditions such as low back pain, osteoarthritis and fibromyalgia, as well as those recovering from surgeries including joint replacements and spinal procedures.  On average, the study found that melatonin reduced pain by around nine points on a 0-100 scale, with the most rigorous trials showing reductions closer to 10 points, a similar magnitude to widely used pain medications. Across the trials, the dose and timing of melatonin varied depending on the condition and setting. For chronic musculoskeletal pain, doses typically ranged from 3 to 10 mg, with 3 mg per day the most commonly used. For postoperative pain, doses ranged from 1 to 10 mg, with 5 to 6 mg most common. Melatonin was generally taken at bedtime or up to one hour before sleep.     Study: Nordic Walking Reduces Depression Symptoms Within Weeks Université Grenoble Alpes (France), July 1 2026 (Natural News)   A randomized controlled trial published in the Journal of Affective Disorders found that supervised Nordic walking significantly reduced depression symptoms in adults with moderate to severe depression. The most pronounced improvements occurred within the first five weeks of the 10-week program, according to researchers. The study enrolled 64 adults, with 48 assigned to Nordic walking and 16 to a non-active control group.   The findings challenge the commonly cited three-month timeframe for exercise benefits on depression. A secondary analysis examined whether participants with severe depression responded differently than those with moderate symptoms. According to the study, Nordic walking is a low-impact activity that engages the upper and lower body using poles, similar to cross-country skiing. The Nordic walking group showed significantly greater reductions in depression symptoms compared to the control group over the full 10 weeks. The largest reduction occurred from baseline to week five, with a large effect size; improvements from week five to week ten were smaller and not statistically significant. Participants with severe depression at baseline experienced even larger and faster improvements in the first five weeks, according to the secondary analysis.   Connection or compulsion: How smartphones can deepen depression in older adults Rutgers University, July 1 2026 (Eurekalert)   Compulsive smartphone habits in older adults can be linked to a higher risk of depression, according to a study led by a Rutgers researcher.  Researchers said their findings raised concerns that technology widely promoted to build connections can instead deepen late-life isolation: While mobile devices can be invaluable lifelines, their impact on mental health depends heavily on the way people use them. A critical distinction, the researchers said, is whether someone uses technology to actively engage with the world or to withdraw. The study, published in JMIR Aging, drew on survey responses from 2,585 adults ages 60 and older living in 87 communities. Researchers collected health and demographic information, including age, gender, marital status, education and income, and measured depressive symptoms with a screening tool commonly used with older adults. Limited social participation emerged as the strongest predictor of depression, followed closely by smartphone addiction, defined as compulsive or excessive use that disrupts daily functioning. Problematic phone reliance appeared in nearly all cases of clinical depression, with older adults who rarely used interactive communication features facing the greatest risk. Another high-risk pattern emerged among older adults of both sexes: Those with higher incomes and education levels who suffered from smartphone addiction were more prone to clinical depression. This finding suggests that wealth, education, and technology access fail to protect against loneliness when screen time replaces real-world connections.   This Popular Workout Supplement May Give Cancer Immunotherapy a Big Boost University of California at Los Angeles, July 1, 2026 (SciTech Daily) Creatine, a supplement widely used by athletes and bodybuilders, may also strengthen the immune system's ability to fight cancer, according to new research from UCLA. Previous findings from the same research team show that creatine boosts the activity of killer T cells, which destroy cancer cells. The new research found that creatine also supports dendritic cells, the immune cells responsible for detecting tumor material and activating killer T cells to launch an attack. Although many approved cancer immunotherapies target killer T cells, only about 20% to 40% of patients benefit from these treatments. Enhancing dendritic cells, which prepare and activate T cells, could improve the effectiveness of immunotherapy for more people. The researchers found that dendritic cells inside tumors produced much higher levels of the gene responsible for the creatine transporter, the protein that moves creatine into cells, than dendritic cells found in healthy tissue. They investigated whether increasing creatine could improve dendritic cell performance. Daily creatine injections in mouse models of melanoma slowed tumor growth while increasing both the number and activity of dendritic cells within tumors. The treated dendritic cells also released more chemical signals that attracted additional immune cells to the tumor.     Probiotic metabolite found to suppress melanoma tumor growth in mice Southern Medical University (China), June 30 2026 (News-Medical)   Immune checkpoint inhibitors like anti-PD-1 have transformed melanoma treatment, yet more than half of patients fail to respond or eventually develop resistance. The tumor microenvironment and the gut microbiome are increasingly recognized as critical determinants of immunotherapy outcomes. Melanoma patients often show reduced levels of beneficial gut bacteria, including Bifidobacterium, and lower microbial diversity. Researchers have discovered that Bifidobacterium animalis—a probiotic commonly found in fermented dairy products—produces mannose, which activates CD8⁺ T cells and suppresses melanoma progression in mouse models. The study reveals a novel gut-microbiome-immune axis that could lead to new adjuvant strategies for melanoma immunotherapy.   When given orally to mice with melanoma tumors, the bacterium significantly reduced tumor volume and weight—without ever colonizing the tumor tissue itself, indicating that its effects were mediated entirely through secreted metabolites. Using size fractionation and metabolomics, the team identified mannose as the key bioactive molecule—a small, non-protein compound under 3 kilodaltons. In mice, drinking water supplemented with 1% mannose replicated the anti-tumor effects of the live probiotic, increasing tumor-infiltrating CD8⁺ T cells and boosting their production of killer molecules like granzyme B (GZMB), interferon-gamma (IFN-γ), and tumor necrosis factor-alpha (TNF-α).

SCOTUS votes 6-3 to uphold birthright citizenship, Kushner and Witkoff meet Qatari mediators in Doha for Iran talks, Keiko Fujimori wins Peru's presidency by a slim margin, South Korea's parliament confirms Han Seong-sook as prime minister, a Ukrainian businessman is among three people injured in a Monaco bomb attack, SCOTUS upholds state transgender sports bans, a Gallup poll shows that economic pessimism among Russians is at its highest in two decades, the U.K. considers blocking Paramount's takeover of Warner Bros Discovery, The New England Journal of Medicine retracts a Tavneos study over data concerns, and researchers find Antarctic sea creatures that may help treat melanoma. Sources: Verity.News

In this episode of the DIGA Podcast, we continue our Dermatology Crash Course mini series with a high-yield discussion on Melanoma led by Dr. Jane Grant-Kels. We hope you enjoy!About the Dermatology Crash Course Series The Dermatology Crash Course is a DIGA Podcast mini-series focused on delivering short, high-yield episodes that cover foundational dermatology topics. Each episode features a dermatologist sharing practical insights to help learners develop confidence in recognizing and managing common skin conditions.---DIGA Instagram: @⁠⁠⁠⁠⁠derminterest⁠⁠⁠⁠⁠Today's Host, Katelyn: @⁠⁠⁠⁠⁠katsteng⁠---For questions, comments, or future episode suggestions, please reach out to us via email at ⁠⁠⁠⁠⁠derminterestpod@gmail.com⁠⁠⁠⁠⁠---District Four by Kevin MacLeodLink: ⁠⁠⁠⁠⁠https://incompetech.filmmusic.io/song/3662-district-four⁠⁠⁠License: ⁠⁠⁠https://filmmusic.io/standard-license

Episode 11: When It's Not Just Ocular Melanoma Living with ocular melanoma is challenging enough—but what happens when other health issues enter the picture, too? In Episode 11 of our special 15-year series, Melody opens up about navigating multiple health conditions while living with ocular melanoma. She discusses the judgment, guilt, and embarrassment that can come with compounding health issues. This honest conversation explores the emotional weight of managing overlapping diagnoses, advocating for yourself in medical settings, and giving yourself permission to acknowledge all of your health challenges without comparison or shame. If you've ever felt like your struggles were minimized, questioned, or misunderstood, this episode is for you.

Today's Case A 79-year-old male from Laos presents to the emergency department with nodules on his left lower extremity that have been slowly enlarging and spreading up his leg for 1 year. He reports weight loss and fatigue and denies any other systemic symptoms. He had just relocated from Laos to the United States. His medical history is generally unknown and he is not on any medications. Today's Reader Jared Fehlman is an Internal Medicine Resident at Huntington Health Hospital in Pasadena, California. About Dr. Raj Dr Raj is a quadruple board certified physician and associate professor at the University of Southern California. He was a co-host on the TNT series Chasing the Cure with Ann Curry, a regular on the TV Show The Doctors for the past 7 seasons and has a weekly medical segment on ABC news Los Angeles. More from Dr. Raj ⁠⁠The Dr. Raj Podcast⁠⁠ ⁠⁠Dr. Raj on Twitter⁠⁠ ⁠⁠Dr. Raj on Instagram⁠⁠ Want more board review content? ⁠⁠USMLE Step 1 Ad-Free Bundle⁠⁠ ⁠⁠Crush Step 1⁠⁠ ⁠⁠Step 2 Secrets⁠⁠ ⁠⁠Beyond the Pearls⁠⁠ ⁠⁠The Dr. Raj Podcast⁠⁠ ⁠⁠Beyond the Pearls Premium⁠⁠ ⁠⁠USMLE Step 3 Review⁠⁠ ⁠⁠MedPrepTGo Step 1 Questions⁠⁠ ⁠⁠MedPrepTGo Step 2 Questions⁠ Learn more about your ad choices. Visit megaphone.fm/adchoices

Dr. Pauline Funchain and Dr. Allison Betof discuss practice-changing and paradigm-shifting abstracts in melanoma, Merkel cell carcinoma, and cellular therapies that were presented at the 2026 ASCO Annual Meeting. LINK TO FULL TRANSCRIPT

This week on The Back of the Pack Podcast, we take you with us to the Outpacing Melanoma 5K, where the podcast set up on-site for a morning of racing, conversations, interviews, and community connection. After previously having the race team on the show to talk about the mission behind the event, we had the chance to be there in person, meet the people behind the cause, and hear directly from those impacted by melanoma and skin cancer. Throughout the morning, we spoke with dermatologists, doctors, nurses, survivors, supporters, runners, and families who all brought their own perspective to why this race matters. We also caught up with Jenny from 106.5 The Wolf, the race director, and plenty of runners who were brave enough, curious enough, or just chaotic enough to step up to the microphone. This episode is less of a traditional race review and more of a race-day field trip into the heart of a community fighting for awareness, prevention, treatment, and hope. For runners, the message hits especially close to home, because hours spent training in the sun can come with real risks if we are not taking care of our skin. We talk about the energy of the event, the people who made it meaningful, and the reminder that every start line can carry a bigger purpose than just miles and finish times. Join us as we share the voices, stories, and mission from a powerful morning at the Outpacing Melanoma 5K.

There's a viral social media post claiming that you're 300% more likely to develop skin cancer when you use sunscreen. What's the truth? Is sunscreen safe to use? In this episode Doctor Motley breaks down the research, and brings a new lens to the debate: what did ancient cultures do for skin health? Here's what you'll learn in this episode: *Research has found chemicals in your sunscreen like oxybenzone can affect your estrogen and testosterone levels and block Vitamin D, - which is an important hormone, not just a vitamin! - plus some healthy sunscreen ingredients to look for. *What is the "sunscreen paradox" *Why heavily sun-protected, indoor populations showed higher melanoma rates in UK research *How to build a solar callus: the traditional method of safe, gradual sun exposure that builds your skin's natural protection *How to create a healthy skin protocol this summer: Develop early morning sun exposure over time, plus take good vitamins (like B3), minerals and herbs! *Skin protection from a TCM perspective: In Chinese Medicine, the strength of the skin is connected to the strength of your lungs. Find out how to protect your skin with TCM herbs. Research: FDA Findings:https://jamanetwork.com/journals/jama/fullarticle/2733085#google_vignette The Sunscreen Paradox https://www.sciencedaily.com/releases/2023/10/231027110724.htm Chemicals in Sunscreen: https://www.ewg.org/sunscreen/report/the-trouble-with-sunscreen-chemicals/ Vitamin B Study: https://www.nejm.org/doi/full/10.1056/NEJMoa1506197 https://doi.org/10.3390/nu17071240 ------  Want more of The Ancient Health Podcast? Subscribe to the YouTube channel. Follow Doctor Motley Instagram Facebook Website ------  *You can get cell support in gummy form: Mitopure now starts at $79, when you go to timeline.com/DRMOTLEY. *Join Doctor Motley's newsletter for TCM insights and regular podcast updates: https://www.doctormotley.com/ *Do you have a ton more in-depth questions for Doctor Motley? Check out his course on emotions and the body in his membership. You'll find other courses full of his expertise and clinical wisdom, plus bring all your questions to his weekly lives! To try risk-free for 15 days click here: https://www.doctormotley.com/15 ------ DISCLAIMER Please remember that the information shared in this podcast is for education purposes only and does not constitute the practice of medicine, nursing, or other professional healthcare services, including the giving of medical advice.   No doctor-patient relationship is formed through this podcast, and the use of information here or materials linked from this podcast is at your own risk.   The content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always consult with your healthcare provider before making any changes to your health regimen, and do not disregard or delay seeking medical advice for any condition you may have.

Can sunlight really improve your health, mood, sleep, heart health, and even lifespan? In this episode of Walk Don't Run to the Doctor, Dr. Miles Hassell breaks down the science behind sunlight exposure, vitamin D, nitric oxide, and why avoiding the sun entirely may actually carry serious health risks. You'll learn the difference between safe sunlight exposure and dangerous sunburn, why sunscreen may not work the way many people think, and how regular outdoor time could improve cardiovascular health, mental health, bone strength, immunity, and more. If you've been told to fear the sun, this evidence-based discussion may completely change how you think about sunlight and wellness. Key Takeaways Why sunlight may lower all-cause mortality and cardiovascular disease risk The surprising limitations of vitamin D supplements How sunlight affects mood, sleep, blood pressure, and metabolism The connection between sun exposure and stronger bones Why avoiding sunburn matters more than avoiding sunlight The truth about sunscreen vs mineral sunblock Practical ways to safely get more sunlight year-round Chapters 00:00 Introduction: Is Sunlight a Vital Nutrient? 00:50 Why People Fear the Sun 01:38 The Proven Health Benefits of Sunlight 02:14 Vitamin D, Nitric Oxide & How Sunlight Works 04:12 Studies Showing Sunlight May Increase Longevity 07:18 Bone Strength, Mood & Better Sleep 10:55 Why Vitamin D Supplements May Not Be Enough 12:23 Melanoma, Sunburn & Real Skin Cancer Risks 15:00 Sunscreen vs Mineral Sunblock Explained 18:09 Safe Sun Exposure Recommendations 19:57 How We Research Health Claims 21:14 Real-Life Lifestyle Medicine Success Stories Do you have a health or nutrition question for Dr. Hassell? Reach out to us: Web: GreatMed.org Call/Text: 503-773-0770 Email: info@GreatMed.org Mail: 4804 NW Bethany Blvd., Suite I-2, #273, Portland, OR 97229 This podcast is fully funded by our generous listeners. Support our mission at GreatMed.org/donate (EIN: 88-326-7056) Get your copy of Good Food Great Medicine, 4th ed.: https://a.co/d/1D6hIYM  #VitaminD #Sunlight #Longevity #HealthPodcast #LifestyleMedicine #DrMilesHassell #HeartHealth #MentalHealth #SunExposure #Wellness #SleepHealth #BoneHealth #PreventiveHealth #HealthyLiving #WalkDontRunToTheDoctor

Eye on the Expert: Eye on ctDNA – What Doctors Are Learning in Uveal Melanoma In this Eye on the Expert webinar, leading experts discuss the growing role of circulating tumor DNA (ctDNA) in uveal melanoma and what this emerging technology may mean for patients and providers. Joining the discussion are: Michael Krainock, Associate Medical Director of Oncology at Natera Dr. Kam Montazeri, Medical Oncologist Dr. Vincent Ma, Medical Oncologist Together, they explore: What ctDNA is and how it is detected through blood testing What doctors are learning about ctDNA in uveal melanoma How ctDNA may be used to monitor disease and treatment response The potential benefits and limitations of this evolving technology Questions patients should ask when considering ctDNA testing As research continues to advance, ctDNA is providing new insights into how cancer can be monitored and understood. This webinar offers an accessible overview of the science, current applications, and future possibilities for patients living with uveal melanoma. Thank you to our sponsors for making this webinar possible: Ideaya Biosciences Delcath Systems Aura Biosciences Castle Biosciences Immunocore Natera Rare Cancer. Resilient Hope. Revolutionary Research.

BUFFALO, NY – June 17, 2026 – A new #research paper was #published in Volume 17 of Oncotarget on June 8, 2026, titled “DHHC3 interferes with antitumor immunity in melanoma cells.” The study was led by first author and corresponding author Chandan Sharma and corresponding author Martin E. Hemler from the Department of Cancer Immunology and Virology at the Dana-Farber Cancer Institute. Melanoma is one of the most aggressive forms of skin cancer and is highly influenced by interactions between tumor cells and the immune system. Although modern immunotherapies have transformed treatment for many patients, researchers continue to search for molecular mechanisms that enable tumors to evade immune attack and continue growing. In this study, researchers investigated DHHC3, a protein acyltransferase that regulates protein palmitoylation and helps maintain cellular redox balance. Previous studies had linked elevated DHHC3 expression to poor outcomes in several cancers, but its role in melanoma and anti-tumor immunity remained unclear. To explore this question, the team used CRISPR gene editing to eliminate DHHC3 expression in B16F10 melanoma cells. Loss of DHHC3 caused a marked increase in oxidative stress and cellular senescence, as demonstrated by elevated TXNIP expression, increased reactive oxygen species levels, and enhanced expression of senescence-associated markers. Full press release - https://www.oncotarget.net/2026/06/17/protein-linked-to-melanoma-growth-may-suppress-the-bodys-natural-anti-tumor-immune-response/ DOI - https://doi.org/10.18632/oncotarget.28880 Correspondence to - Martin E. Hemler - martin_hemler@dfci.harvard.edu, and Chandan Sharma - csharma@mgh.harvard.edu Abstract video - https://www.youtube.com/watch?v=QQhP2VhzKSE Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28880 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, oxidative stress, DHHC3, anti-cancer immunity, palmitoylation, melanoma To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Skin Cancer Prevention, Anti-Aging Biohacking, and the Melanoma Detection Gap Most dermatologists are missing melanoma, and a board-certified skin cancer specialist explains exactly why, and what to do about it. This episode covers the detection tool that finds 10 times more melanomas, the real truth about sunscreen chemicals, the biohacking peptide that can hide cancer on your skin, and the cheap anti-aging drug that most people have never tried. -Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Host Dave Asprey sits down with Dr. Michael Christopher, a board-certified dermatologist and expert dermoscopist recognized for his work in early melanoma detection. Through consistent, evidence-based use of dermoscopy, he identifies between 150 and 215 melanomas annually, far exceeding national and state averages and exposing a critical gap in standard skin cancer screening. Dr. Christopher speaks regularly on prevention, early detection, and systemic failures in dermatology training across health, wellness, and longevity-focused media, and has made it his mission to change the standard of care before more people die from a cancer that is almost always curable when caught early. Dave and Dr. Christopher break down why a standard skin exam with no additional tools is essentially a guess, how dermoscopy changes everything, and why most dermatologists who claim to use it actually cannot interpret what they see. They get into the real risk factors for rising melanoma rates, what sunscreen labels are not telling you, and how melanotan and other biohacking peptides interact with your skin cancer risk in ways that matter. They also cover tretinoin as one of the most evidence-backed anti-aging and skin optimization tools available, how red lighttherapy supports mitochondria function and skin rejuvenation, and what parents should know about protecting their kids' skin for long-term longevity You'll Learn: Why most dermatologists miss melanoma and what the detection gap actually looks like What dermoscopy is, how it works, and why you should ask for it by name How melanoma survival drops from 99% at stage one to 73% at stage three What the Prop 65 cancer warning on most pharmacy sunscreens actually means Why visible light can darken your skin even when you wear sunscreen How melanotan activates melanocortin receptors and why that may affect melanoma risk What Retin-A does to collagen, the epidermis, and long-term skin aging How AI is entering dermoscopy and where it still falls short The right concentration of tretinoin to start with and how to get through the adjustment period What parents should do now to protect their kids from melanoma later Thank you to our sponsors! -Beyond Wonderland Conference | Oct 13 - 14, 2026. Get your ticket now at wonderlandconference.com.-Viome | Check it out at viome.com and use code 10DAVE for 10% off. It's time to stop guessing and start knowing your body.-Timeline | Go to timeline.com/dave and you'll get an additional 20% off your first month-Redmond Real - Leaf Toothpaste | Go to https://redmond.com/asprey and use code ASPREY for 15% off your first order.Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights inhealth, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: Michael Christopher, Dr. Michael Christopher, melanoma detection, dermoscopy, dermatoscope, skin cancer screening, melanoma prevention, early melanoma detection, skin cancer biohacking, sunscreen toxins, Prop 65 sunscreen, mineral sunscreen, zinc oxide, titanium dioxide, melanotan, melanocortin, skin aging, anti-aging, tretinoin, Retin-A, retinol, skin rejuvenation, collagen, red light therapy, mitochondria, UV exposure, UVB light, skin cancer longevity, melanoma survival rate, squamous cell carcinoma, functional medicine, human performance, longevity, biohacking, supplements, skin optimization, dermoscopy AI, skin cancer AI, visible light tanning, omega-6 sunburn, astaxanthin, skin health, melanoma staging, skin exam, skin cancer prevention Resources: • Learn More About Dr. Christopher's Work At: https://www.instagram.com/michael_christopher_md/ • Purchase Dr. Fotuhi's New Book The Invincible Brain: https://a.co/d/0iHCgPpL • Get My 2026 Clean Nicotine Roadmap | Enroll for free at https://daveasprey.com/2026-clean-nicotine-roadmap/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Join My Substack (Live Access To Podcast Recordings): https://substack.daveasprey.com/ • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 – Trailer 1:41 – Guest Introduction 3:59 – Dermatoscope Explained 12:27 – Melanoma Rising: Why 16:57 – Melanotan & Sun Risk 21:14 – Melanoma & Longevity 22:31 – Stage 1 vs Stage 3 26:05 – Retin-A Deep Dive 38:53 – Loose Skin Solutions 41:26 – Kids' Skin Health See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Edomex impulsa proyectos científicos y ambientales Inundación cierra Circuito Exterior Mexiquense en TultitlánBolivia libera bloqueos tras seis semanas de protestasMás información en nuestro Podcast#grc

Prime Minister Anthony Albanese has paid tribute to world-renowned melanoma pathologist Richard Scolyer, describing him as a "truly remarkable man" and announcing a state funeral will be held. The 2024 Australian of the Year died on Sunday aged 59, three years after being diagnosed with brain cancer. - Умер выдающийся австралийский учёный Ричард Сколиер. Ему было 59 лет. На протяжении нескольких лет он боролся с раком головного мозга, используя собственный случай для продвижения научных исследований и помощи будущим пациентам. Премьер-министр Австралии Энтони Альбанезе почтил память всемирно известного специалиста по меланоме Ричарда Сколиера, назвав его «по-настоящему выдающимся человеком», и объявил, что ему будут организованы государственные похороны.Больше историй, интервью и новостей от SBS Russian доступно здесь.Включайте радио в понедельник, четверг и субботу в 12.00 Мельбурн — 93.1 fm, Сидней — 97.7 fm, другие города. Подключайтесь к эфиру на нашем сайте и в приложении SBS Audio app.

Join the Behind the Knife Surgical Oncology Team as we discuss clinical challenges through case-based examples including the diagnosis, workup, and management of patients with cutaneous melanoma. Learning Objectives:In this episode, we review the workup and management of patients with cutaneous melanoma and both microscopic and macroscopic nodal disease. References used in the making of this episode: Reijers, I.L.M., Menzies, A.M., van Akkooi, A.C.J. et al. Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial. Nat Med 28, 1178–1188 (2022). https://doi.org/10.1038/s41591-022-01851-x Christian U. Blank et al. Neoadjuvant nivolumab plus ipilimumab versus adjuvant nivolumab in macroscopic, resectable stage III melanoma: The phase 3 NADINA trial.. J Clin Oncol 42, LBA2-LBA2(2024). DOI:10.1200/JCO.2024.42.17_suppl.LBA2 Faries MB, Thompson JF, Cochran AJ, et al. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017;376(23):2211-2222. doi:10.1056/NEJMoa1613210   https://pubmed.ncbi.nlm.nih.gov/28591523/ National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cutaneous Melanoma. Version 1.2026. Accessed April 8, 2026. NCCN Guidelines PDF   Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

This is a practical conversation on circadian living — how to structure your day around light, darkness, food, movement and sleep in a way that supports your biology. We also explore the modern mismatch of indoor LED lighting, artificial light at night, late eating, phone use before bed, blue blockers, beeswax candles, incandescent light, night driving, flicker, skin cancer nuance, sun exposure, DHA, omega-3s and the deeper philosophical implications of living in rhythm with nature. CONSULT DR MAX

Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Population Skin Cancer Screening and Melanoma Mortality Rates

Interview with Joachim Hübner, MD, SJD, and Alexander Katalinic, MD, authors of Population Skin Cancer Screening and Melanoma Mortality Rates. Hosted by Adewole S. Adamson, MD, MPP. Related Content: Population Skin Cancer Screening and Melanoma Mortality Rates

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the death of Bulls legend Stacey King, a new study that shows flu medications have the potential to reduce cognitive decline as well as premature aging in people living with HIV, and an experimental vaccine from Moderna […]

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital, joins John Williams to talk about the death of Bulls legend Stacey King, a new study that shows flu medications have the potential to reduce cognitive decline as well as premature aging in people living with HIV, and an experimental vaccine from Moderna […]

In today's episode, the rising rates of melanoma skin cancer in the UK - why is this happening? Also, evidence that pregnancy induces epigenetic changes to brain gene expression, researchers produce the world's first artificial bird egg to bring back the Dodo, and an electrical technique to discover the composition of the best coffee... Like this podcast? Please help us by supporting the Naked Scientists

In this episode of More Than a Pretty Face, Dr. Azi and Lacie dive into sun safety, skin cancer awareness, sunscreen myths, and the importance of early detection. In honor of Skin Cancer Awareness Month, and with support from the Melanoma Research Foundation, this episode breaks down what you need to know about melanoma, SPF, tanning, and protecting your skin all summer long.  Timeline of what was discussed: 00:00 – Intro 02:00 – Melanoma Awareness 03:30 – Beauty or Blemish 04:10 – Sun Myths 06:00 – Sunburn Damage 08:30 – UV & Skin Cells 10:00 – Skincare Break 11:00 – Tanning Truth 13:00 – UVA vs UVB 14:30 – Skin Cancer Types 16:30 – Skin Cancer in All Skin Tones 18:30 – Skin Checks 20:00 – Melanoma Research Foundation 21:30 – Sunscreen Types 23:00 – Tinted SPF 24:30 – Missed SPF Areas 26:00 – Lips, Scalp & Eyelids 27:30 – TikTok Sunscreen Myths 29:00 – Perineum Tanning 30:00 – Sunscreen Safety 31:30 – How Much SPF to Use 33:00 – Reapplication 35:00 – SPF Numbers 37:00 – Sensitive Skin SPF 39:00 – Family Sun Safety 41:00 – Final Sun Tips 43:00 – Outro ______________________________________________________________ Follow Melanoma Research Foundation on Instagram: @CureMelanoma The Melanoma Research Foundation is the largest independent organization dedicated to melanoma research, education, and advocacy. Focused on advancing early detection, prevention, and treatment, the foundation works to support patients and families affected by melanoma while funding critical research aimed at improving outcomes and ultimately finding a cure. Learn more about Melanoma Research Foundation: linktr.ee/melanomaresearchfoundation  Shop EltaMD Sunscreen Limited Edition: eltamd.com/product  ______________________________________________________________ Submit your questions for the podcast to Dr. Azi on Instagram @morethanaprettyfacepodcast, @skinbydrazi, @nurselacie, on YouTube, and TikTok @skinbydrazi. Email morethanaprettyfacepodcast@gmail.com. Shop skincare at https://azimdskincare.com and learn more about the practice at https://www.lajollalaserderm.com/ The content of this podcast is for entertainment, educational, and informational purposes and does not constitute formal medical advice. © Azadeh Shirazi, MD FAAD.  

What happens when the spot everyone keeps treating… should've been biopsied?In this deeply personal episode of Plastic Surgery Uncensored, Dr. Rady Rahban sits down with Valerie, a vibrant 40-year-old woman whose “sun spot” was dismissed, lasered, peeled, and treated for years—before finally being diagnosed as invasive melanoma.This conversation is equal parts shocking, educational, and incredibly important.Valerie shares the emotional reality of hearing the words “you have melanoma,” while Dr. Rahban breaks down the dangerous misconception that skin cancer always looks obvious, raised, or alarming.Together, they unpack:• Why melanoma can look deceptively harmless• The warning signs people (and even providers) can miss• Why persistence and self-advocacy matter• The critical role of annual dermatology checks• What happens when skin cancer affects the face—and why reconstruction decisions matter more than most patients realize.This episode is not fear-mongering—it's empowerment.Because sometimes the most dangerous diagnosis starts as the spot you were told not to worry about. And when it comes to your health, “probably nothing” should never be the end of the conversation.✨ If you enjoyed this episode of Plastic Surgery Uncensored:✔️ Subscribe on Apple Podcasts, Spotify, or wherever you listen.✔️ Rate & Review—your feedback helps more people find us.✔️ Follow Dr. Rady Rahban across all platforms for daily insights, behind-the-scenes, and patient education:Instagram: @drradyrahbanTikTok: @radyrahbanMDYouTube: @Rady RahbanFacebook: @Rady Rahban✔️ Share this episode with someone considering plastic surgery—the right knowledge can save a life.

Tim Conway Jr Show Hour 3 (5.7) It’s Melanoma Monday, and Tim asks the important question: Do you know how to identify melanoma before it becomes dangerous? The crew breaks down the ABCDE warning signs of melanoma: Asymmetry, Border irregularity, Color changes, Diameter larger than about 6mm, and Evolving spots. A new mole, a changing spot, or one that looks different from the rest — the “ugly duckling” sign — should be checked by a doctor. Plus, a reminder to check your skin regularly, look at both sun-exposed and hidden areas, and take any unusual, bleeding, itching, growing, or changing spot seriously. Early detection can make a major difference. Clean Segment Line: Ask Melanoma Monday: How to identify melanoma and when to get a suspicious mole checked. SEO Keywords / Tags: Melanoma Monday, how to identify melanoma, ABCDE melanoma signs, skin cancer warning signs, suspicious mole, ugly duckling mole, skin check, dermatologist, early melanoma detection, skin cancer awareness, Tim Conway Jr. See omnystudio.com/listener for privacy information.